A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.

Engineering microbes could be our best hope for creating enough antiviral drugs. As fears spread about a potential flu pandemic, Roche's antiviral drug Tamiflu (oseltamivir phosphate) has found ...

Oseltamivir (as phospate ... Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. Not recommended for patients with ESRD ...

Tamiflu is one of four antiviral medications approved by the Food and Drug Administration (FDA) for the treatment of influenza. Antivirals work by preventing a virus from replicating in the body ...

View Full Profile. Learn about our Editorial Policies. The drug works by blocking the flu virus’s ability to use the host cell for replication. That’s a different mechanism from oseltamivir (Tamiflu), ...

Sanofi has made a bold play to bolster its consumer health business, licensing non-prescription rights to Roche’s influenza drug Tamiflu – even though there’s no guarantee it will be ...

It has already made Tamiflu in its lab. The drug has not been as well known and popular as Tamiflu has but is cheaper and sometimes a better alternative to Tamiflu. Dr Y K Hameid, CEO of Cipla in ...

with baloxavir and oseltamivir achieving a 75% and 50% survival rate, respectively. “We showed our existing antivirals’ effectiveness against H5N1 bird flu is route and drug dependent ...

A doctor told Amanda Franks that the side effects of Tamiflu would be worse than the flu Jason Hahn is a former Human Interest and Sports Reporter for PEOPLE. He started at PEOPLE's Los Angeles ...